Pharsight

Gilead patents expiration

1. Letairis patents expiration

LETAIRIS's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8377933 GILEAD Method for treating a pulmonary hypertension condition
Dec, 2027

(3 years from now)

US9474752 GILEAD Method for treating a pulmonary hypertension condition
Dec, 2027

(3 years from now)

US9549926 GILEAD Compositions and methods of treating pulmonary hypertension
Oct, 2031

(7 years from now)

Drugs and Companies using AMBRISENTAN ingredient

Market Authorisation Date: 15 June, 2007

Treatment: For the treatment of pulmonary hypertension (pah) in combination with tadalafil; For the treatment of pulmonary arterial hypertension (pah) in combination with tadalafil, wherein the weight ratio of a...

Dosage: TABLET;ORAL

How can I launch a generic of LETAIRIS before it's drug patent expiration?
More Information on Dosage

LETAIRIS family patents

Family Patents

2. Truvada patents expiration

TRUVADA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9744181 GILEAD Compositions and methods for combination antiviral therapy
Jan, 2024

(2 months ago)

US8592397 GILEAD Compositions and methods for combination antiviral therapy
Jan, 2024

(2 months ago)

US9457036 GILEAD Compositions and methods for combination antiviral therapy
Jan, 2024

(2 months ago)

US8716264 GILEAD Compositions and methods for combination antiviral therapy
Jan, 2024

(2 months ago)

Drugs and Companies using EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE ingredient

Market Authorisation Date: 02 August, 2004

Treatment: Treatment of hiv infection; Treatment of hiv; Method of treatment of adults infected with hiv-1; Treatment of hiv-1 infection in pediatric patients 12 years of age and older

Dosage: TABLET;ORAL

How can I launch a generic of TRUVADA before it's drug patent expiration?
More Information on Dosage

TRUVADA family patents

Family Patents